News & Analysis on Clinical Trial Services & Contract Research And Development
Lonza: capsule manufacturing expansion
By Jenni Spinner
- Last updated on
Lonza is investing $93m in eight facilities around the globe. The move is expected to expand capsule manufacturing capacity within its Capsugel portfolio by about 30b capsules each year.
This investment is expected to be made over two fiscal years, 2020 and 2021. The company reports the expansion supports the strategic position of capsules within nutrition and support introduction of new dosage technologies, such as lipid multi-particulates (LPM) technologies and new time-release capsule solutions.